RxDoctor Payments Data

Sarah Fabry, DO

Family Medicine · Walhalla, SCNPI 1154703783

Payments from drug & device makers

$681in general payments, 2019–2025

Across 82 payments — averaging $8.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zyla Life Sciences, Inc.$171
  • Novo Nordisk$118
  • Pfizer$76
  • Lilly USA, LLC$59
  • Abbott$58
  • AbbVie$45
  • plus $154 from 8 others

What the payments were for

  • Food & beverage$67799%
  • Education$41%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$681 in reported general payments places this provider in the 55th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$36,976
Medicare patients
117
Services billed
307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$36,214
OzempicSemaglutide25$30,426
JardianceEmpagliflozin22$27,804
RybelsusSemaglutide12$18,910
MounjaroTirzepatide13$12,890
Advair HfaFluticasone Propion/Salmeterol15$5,889
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$3,720
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$3,371
Humalog Kwikpen U-100Insulin Lispro14$3,122
Gabapentin132$2,307
Diclofenac Sodium24$1,878
Levothyroxine Sodium136$1,712
Memantine Hcl27$1,605
Tramadol Hcl62$1,592
Pantoprazole Sodium99$1,574

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$118$49,33737 claims
PfizerEliquis$76$36,21427 claims
Lilly USA, LLCMounjaro$59$12,89013 claims
AbbVieSynthroid$45$70111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Walhalla

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →